Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 22:55:39 UTC
Update Date2021-09-26 23:17:47 UTC
HMDB IDHMDB0259934
Secondary Accession NumbersNone
Metabolite Identification
Common NameN-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide
DescriptionN-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide, also known as XL 765 or voxtalisib, belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene. Based on a literature review a significant number of articles have been published on N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
XL 765ChEBI
XL-765ChEBI
N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulphamoyl)phenyl]-3-methoxy-4-methylbenzamideGenerator
VoxtalisibHMDB
Chemical FormulaC31H29N5O6S
Average Molecular Weight599.66
Monoisotopic Molecular Weight599.183854848
IUPAC NameN-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide
Traditional NameN-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide
CAS Registry NumberNot Available
SMILES
COC1=CC(OC)=CC(NC2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(NC(=O)C3=CC(OC)=C(C)C=C3)C=C2)=C1
InChI Identifier
InChI=1S/C31H29N5O6S/c1-19-9-10-20(15-28(19)42-4)31(37)33-21-11-13-25(14-12-21)43(38,39)36-30-29(34-26-7-5-6-8-27(26)35-30)32-22-16-23(40-2)18-24(17-22)41-3/h5-18H,1-4H3,(H,32,34)(H,33,37)(H,35,36)
InChI KeyHJSSPYJVWLTYHG-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassAnilides
Direct ParentBenzanilides
Alternative Parents
Substituents
  • Benzanilide
  • Diazanaphthalene
  • Quinoxaline
  • Dimethoxybenzene
  • M-dimethoxybenzene
  • Benzenesulfonamide
  • Methoxyaniline
  • Benzoic acid or derivatives
  • Benzamide
  • Toluamide
  • P-toluamide
  • Benzenesulfonyl group
  • Methoxybenzene
  • Anisole
  • Benzoyl
  • Phenol ether
  • Aniline or substituted anilines
  • Phenoxy compound
  • Aminopyrazine
  • Alkyl aryl ether
  • Toluene
  • Pyrazine
  • Imidolactam
  • Organosulfonic acid amide
  • Organosulfonic acid or derivatives
  • Organic sulfonic acid or derivatives
  • Aminosulfonyl compound
  • Sulfonyl
  • Heteroaromatic compound
  • Secondary carboxylic acid amide
  • Amino acid or derivatives
  • Carboxamide group
  • Secondary amine
  • Organoheterocyclic compound
  • Azacycle
  • Carboxylic acid derivative
  • Ether
  • Organic nitrogen compound
  • Amine
  • Hydrocarbon derivative
  • Organic oxide
  • Organosulfur compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Organonitrogen compound
  • Organooxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP4.94ALOGPS
logP5.55ChemAxon
logS-5.4ALOGPS
pKa (Strongest Acidic)6.11ChemAxon
pKa (Strongest Basic)-0.43ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count9ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area140.77 ŲChemAxon
Rotatable Bond Count9ChemAxon
Refractivity163.36 m³·mol⁻¹ChemAxon
Polarizability63.85 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
AllCCS[M+H]+241.83332859911
AllCCS[M+H-H2O]+240.5232859911
AllCCS[M+Na]+243.3532859911
AllCCS[M+NH4]+243.01632859911
AllCCS[M-H]-220.72932859911
AllCCS[M+Na-2H]-221.62932859911
AllCCS[M+HCOO]-222.77132859911
DeepCCS[M+H]+231.73630932474
DeepCCS[M-H]-229.89430932474
DeepCCS[M-2H]-263.13430932474
DeepCCS[M+Na]+237.35530932474

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. 5.7 minutes32390414
Predicted by Siyang on May 30, 202216.0215 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20221.49 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid3141.1 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid218.2 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid221.8 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid170.7 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid187.2 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid803.9 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid763.6 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)85.9 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid1465.0 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid639.2 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1710.2 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid416.2 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid515.4 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate120.3 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA87.5 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water10.2 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamideCOC1=CC(OC)=CC(NC2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(NC(=O)C3=CC(OC)=C(C)C=C3)C=C2)=C17101.2Standard polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamideCOC1=CC(OC)=CC(NC2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(NC(=O)C3=CC(OC)=C(C)C=C3)C=C2)=C15156.0Standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamideCOC1=CC(OC)=CC(NC2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(NC(=O)C3=CC(OC)=C(C)C=C3)C=C2)=C15661.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TMS,isomer #1COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)[Si](C)(C)C)=C15414.3Semi standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TMS,isomer #1COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)[Si](C)(C)C)=C14775.9Standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TMS,isomer #1COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)[Si](C)(C)C)=C17420.2Standard polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TMS,isomer #2COC1=CC(NC2=NC3=CC=CC=C3N=C2N([Si](C)(C)C)S(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)=CC(OC)=C15464.0Semi standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TMS,isomer #2COC1=CC(NC2=NC3=CC=CC=C3N=C2N([Si](C)(C)C)S(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)=CC(OC)=C14898.1Standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TMS,isomer #2COC1=CC(NC2=NC3=CC=CC=C3N=C2N([Si](C)(C)C)S(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)=CC(OC)=C17598.0Standard polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TMS,isomer #3COC1=CC(NC2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C)C=C2)=CC(OC)=C15303.0Semi standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TMS,isomer #3COC1=CC(NC2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C)C=C2)=CC(OC)=C14655.0Standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TMS,isomer #3COC1=CC(NC2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C)C=C2)=CC(OC)=C17645.4Standard polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TMS,isomer #1COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2N([Si](C)(C)C)S(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)[Si](C)(C)C)=C15120.5Semi standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TMS,isomer #1COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2N([Si](C)(C)C)S(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)[Si](C)(C)C)=C14879.2Standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TMS,isomer #1COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2N([Si](C)(C)C)S(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)[Si](C)(C)C)=C16891.1Standard polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TMS,isomer #2COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C)C=C2)[Si](C)(C)C)=C14981.3Semi standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TMS,isomer #2COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C)C=C2)[Si](C)(C)C)=C14586.0Standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TMS,isomer #2COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C)C=C2)[Si](C)(C)C)=C16848.0Standard polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TMS,isomer #3COC1=CC(NC2=NC3=CC=CC=C3N=C2N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C)C=C2)=CC(OC)=C15038.1Semi standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TMS,isomer #3COC1=CC(NC2=NC3=CC=CC=C3N=C2N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C)C=C2)=CC(OC)=C14846.8Standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TMS,isomer #3COC1=CC(NC2=NC3=CC=CC=C3N=C2N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C)C=C2)=CC(OC)=C17052.4Standard polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,3TMS,isomer #1COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C)C=C2)[Si](C)(C)C)=C14769.5Semi standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,3TMS,isomer #1COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C)C=C2)[Si](C)(C)C)=C14854.6Standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,3TMS,isomer #1COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C)C=C2)[Si](C)(C)C)=C16431.3Standard polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TBDMS,isomer #1COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)[Si](C)(C)C(C)(C)C)=C15618.7Semi standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TBDMS,isomer #1COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)[Si](C)(C)C(C)(C)C)=C14932.6Standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TBDMS,isomer #1COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)[Si](C)(C)C(C)(C)C)=C17292.0Standard polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TBDMS,isomer #2COC1=CC(NC2=NC3=CC=CC=C3N=C2N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)=CC(OC)=C15704.0Semi standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TBDMS,isomer #2COC1=CC(NC2=NC3=CC=CC=C3N=C2N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)=CC(OC)=C15100.2Standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TBDMS,isomer #2COC1=CC(NC2=NC3=CC=CC=C3N=C2N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)=CC(OC)=C17456.2Standard polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TBDMS,isomer #3COC1=CC(NC2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C(C)(C)C)C=C2)=CC(OC)=C15555.5Semi standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TBDMS,isomer #3COC1=CC(NC2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C(C)(C)C)C=C2)=CC(OC)=C14853.2Standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,1TBDMS,isomer #3COC1=CC(NC2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C(C)(C)C)C=C2)=CC(OC)=C17512.9Standard polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TBDMS,isomer #1COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)[Si](C)(C)C(C)(C)C)=C15554.2Semi standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TBDMS,isomer #1COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)[Si](C)(C)C(C)(C)C)=C15270.0Standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TBDMS,isomer #1COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(C)C(OC)=C3)C=C2)[Si](C)(C)C(C)(C)C)=C16744.8Standard polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TBDMS,isomer #2COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)=C15448.7Semi standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TBDMS,isomer #2COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)=C14996.9Standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TBDMS,isomer #2COC1=CC(OC)=CC(N(C2=NC3=CC=CC=C3N=C2NS(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)=C16734.9Standard polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TBDMS,isomer #3COC1=CC(NC2=NC3=CC=CC=C3N=C2N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C(C)(C)C)C=C2)=CC(OC)=C15514.6Semi standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TBDMS,isomer #3COC1=CC(NC2=NC3=CC=CC=C3N=C2N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C(C)(C)C)C=C2)=CC(OC)=C15270.7Standard non polar33892256
N-[4-({3-[(3,5-Dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide,2TBDMS,isomer #3COC1=CC(NC2=NC3=CC=CC=C3N=C2N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N(C(=O)C3=CC=C(C)C(OC)=C3)[Si](C)(C)C(C)(C)C)C=C2)=CC(OC)=C16891.8Standard polar33892256
Spectra
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID24747393
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound49867926
PDB IDNot Available
ChEBI ID71958
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]